About
Laurent Pharmaceuticals is a Montreal-based clinical-stage biotechnology company developing small-molecule therapies for degenerative conditions. Its lead candidate, LAU-7b, is in Phase 2 clinical development and is designed to simultaneously target multiple molecular pathways.
Explore Laurent Pharmaceuticals's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.